Company Name or Ticker Symbol
Search for other Categories

Idera Pharmaceuticals, Inc.  (IDRA)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs

IDRA's Revenue Year on Year Growth by Quarter and Year

Idera Pharmaceuticals,'s Revenue results by quarter and year

Select the Comparisons : Select the Ratio:                        
IDRA Revenue (in millions $) FY 2016 FY 2015 FY 2014 FY 2013
IV Quarter December 15.28 0.19 - -
III Quarter September 0.32 0.02 0.03 0.01
II Quarter June 0.30 0.01 0.04 0.03
I Quarter March 0.29 0.03 - 0.01
FY   16.19 0.25 0.07 0.05

Financial Statements
Idera Pharmaceuticals,'s forth quarter 2016 Revenue $ 15.28 millions IDRA's Income Statement
Idera Pharmaceuticals,'s forth quarter 2015 Revenue $ 0.19 millions Quarterly IDRA's Income Statement
IDRA's Growth by Division See IDRA's Growth by Segment

IDRA Revenue ( Y/Y Growth %) 2016
2015 2014 2013
IV Quarter December 7942.63 % - - -
III Quarter September 1500 % -33.33 % 200 % -
II Quarter June 2900 % -75 % 33.33 % 0 %
I Quarter March 866.67 % - - 0 %
FY   6376.4 % 257.14 % 40 % -

IDRA Revenue Growth Comment
Idera Pharmaceuticals, Inc. achieved in the forth quarter, above Company average Revenue surge of 7942.63% year on year, to $ 15.28 millions.

Among companies who have reported forth quarter results in the Biotechnology & Drugs industry only one Company has achieved higher year on year Revenue results in the forth quarter. While Idera Pharmaceuticals, Inc.' s Revenue doubling of 7942.63% ranks overall at the positon no. 17 in the forth quarter.

Revenue Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #2
Healthcare Sector #4
S&P 500 #17
Revenue Y/Y Growth Statistics
High Average Low
9400 % 1672.44 % -86.84 %
(Dec 31 2015)   (Jun 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
IDRA's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for IDRA's Competitors
Revenue Growth for Idera Pharmaceuticals,'s Suppliers
Revenue Growth for IDRA's Customers

You may also want to know
IDRA's Annual Growth Rates IDRA's Profitability Ratios IDRA's Asset Turnover Ratio IDRA's Dividend Growth
IDRA's Roe IDRA's Valuation Ratios IDRA's Financial Strength Ratios IDRA's Dividend Payout Ratio
IDRA's Roa IDRA's Inventory Turnover Ratio IDRA's Growth Rates IDRA's Dividend Comparisons

Companies with similar Revenue doubling for the quarter ending Dec 31 2016 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2016
Arrowhead Research Corp  9,878.28 %$ 9,878.277 millions
Idera Pharmaceuticals, Inc.  7,942.63 %$ 7,942.632 millions
Fortress Biotech, Inc.  4,775.74 %$ 4,775.740 millions

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales

Event Calendar
OIIM's Profile
Stock Price
OIIM's Financials
OIIM's Expectations
Business Description
Charts & Quotes
OIIM's News
OIIM's Competitors
Customers & Markets
Economic Indicators
OIIM's Growth
Company Segments

At a Glance
Growth Rates
Financial Strength

At a Glance
Sectors & Industries

Stock Performance
Growth Rates
Financial Strength
Management Effectivness

At a Glance

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms

About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com